{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:00:38Z","timestamp":1778202038685,"version":"3.51.4"},"reference-count":22,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T00:00:00Z","timestamp":1282867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Interven Cardiology"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:p> <jats:bold>\n            <jats:italic>Background:<\/jats:italic>\n          <\/jats:bold>\u2002<jats:italic>Contrast nephropathy (CIN) increases adverse clinical outcomes. We examine risks and clinical predictors of CIN in patients undergoing percutaneous coronary intervention (PCI) and effectiveness of prophylactic therapy.<\/jats:italic><\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Methods:<\/jats:italic>\n          <\/jats:bold>\u2002<jats:italic>A cohort of 8,798 patients who underwent PCI from May 2000 to April 2008 was enrolled. We divided patients into 3 groups. A: STEMI patient undergoing primary PCI; B: UA\/NSTEMI patients undergoing early PCI; C: Patients without MI undergoing elective PCI. Pre\u2010PCI saline hydration was given to group B and C if baseline glomerular filtration rate (GFR) &lt;60 ml\/min\/1.73 m<jats:sup>2<\/jats:sup>.<\/jats:italic><\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Results:<\/jats:italic>\n          <\/jats:bold>\u2002<jats:italic>Mean age was 57.4 years; 35.9% was diabetics. Incidence of CIN were 12.0%, 9.2%, and 4.5%, in group A, B and C (P = &lt;0.0005). CIN correlated with higher mortality (15.5% vs. 1.3%, P &lt; 0.0005) at 1 month. The important predictors of CIN were age &gt;70, female gender, anemia, low systolic BP &lt; 100 mmHg, high creatinine kinase level, abnormal LVEF, baseline renal impairment, MI and insulin dependent diabetes. Incidence of CIN in patients with GFR &gt;60 were 8.2%, 9.2%, and 4.3% in group A, B, and C respectively (p &lt; 0.0005). Incidence of CIN in patients with GFR = 30\u201360 were 19.1%, 4.5%, and 2.4% (p &lt; 0.0005) and in patients with GFR &lt; 30 were 34.4%, 40.0%, and 25.9% (p = 0.510).<\/jats:italic><\/jats:p><jats:p> <jats:bold>\n            <jats:italic>Conclusions:<\/jats:italic>\n          <\/jats:bold>\u2002<jats:italic>Pre\u2010hydration prophylaxis was effective in preventing CIN in mild renal impaired patients (GFR 30\u201360) but are less so in more severely renal impaired patients (GFR &lt; 30). STEMI patients undergoing primary PCI regardless of baseline GFR were at high risk. Accelerated prophylactic regime can be considered in this cohort.<\/jats:italic> (J Interven Cardiol 2010;23:451\u2013459)<\/jats:p>","DOI":"10.1111\/j.1540-8183.2010.00581.x","type":"journal-article","created":{"date-parts":[[2010,8,30]],"date-time":"2010-08-30T18:51:36Z","timestamp":1283194296000},"page":"451-459","source":"Crossref","is-referenced-by-count":55,"title":["Comparison of Risks and Clinical Predictors of Contrast\u2010Induced Nephropathy in Patients Undergoing Emergency versus Nonemergency Percutaneous Coronary Interventions"],"prefix":"10.1111","volume":"23","author":[{"given":"ERIC","family":"CHONG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIAN K.","family":"POH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SHEN","family":"LIANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHAO Y.","family":"SOON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HUAY\u2010CHEEM","family":"TAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,27]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8183.2007.00260.x"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198901193200303"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.28.9.1140"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0195-668X(02)00618-8"},{"key":"e_1_2_6_7_2","unstructured":"Circulation 2004 110 ACC\/AHA Guidelines for the Management of Patients With ST\u2010Elevation Myocardial Infarction\u2014Executive Summary. A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction)"},{"key":"e_1_2_6_8_2","article-title":"ACC\/AHA\/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention\u2014Summary Article A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention Sidney C","volume":"113","author":"Chair S","year":"2006","journal-title":"Circulation"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000016043.87291.33"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-131-1-199907060-00010"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000103623.63687.21"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(03)00147-4"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/heart.89.9.1003"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-9-200911030-00008"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(03)00487-X"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199809173391203"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054209"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehj.2004.08.016"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-137-7-200210010-00006"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0828-282X(08)70193-4"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21207"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2009.07.015"}],"container-title":["Journal of Interventional Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8183.2010.00581.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8183.2010.00581.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T08:25:59Z","timestamp":1698913559000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8183.2010.00581.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,27]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["10.1111\/j.1540-8183.2010.00581.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8183.2010.00581.x","archive":["Portico"],"relation":{},"ISSN":["0896-4327","1540-8183"],"issn-type":[{"value":"0896-4327","type":"print"},{"value":"1540-8183","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,27]]}}}